| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | China | 6 | |
| #3 | Australia | 5 | |
| #4 | Canada | 4 | |
| #5 | EPO (European Patent Office) | 4 | |
| #6 | Israel | 4 | |
| #7 | WIPO (World Intellectual Property Organization) | 4 | |
| #8 | EAPO (Eurasian Patent Organization) | 3 | |
| #9 | Republic of Korea | 3 | |
| #10 | Brazil | 2 | |
| #11 | Mexico | 2 | |
| #12 | Hong Kong | 1 | |
| #13 | Japan | 1 | |
| #14 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Special acyclic compounds | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | He Wei | 41 |
| #2 | Wei He | 2 |
| Publication | Filing date | Title |
|---|---|---|
| TW201922256A | Methods for treating lymphoid malignancies | |
| WO2017218844A2 | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | |
| AU2015252654A1 | Polyfluorinated compounds acting as Bruton's tyrosine kinase inhibitors | |
| CN106146508A | The drug combination optimized and treatment cancer and the purposes of autoimmune disease thereof | |
| WO2014146486A1 | Three-level cyclic amine alk kinase inhibitor for treating cancer |